| |
| |
|
| Insider
Information: |
Davis Thomas Andrew |
| Relationship: |
CHIEF MEDICAL OFFICER |
| City: |
Gaithersburg |
| State: |
X1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
74,341 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$77,308 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
74,341 |
|
|
| Total
Value |
$77,308 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genvec Inc |
GNVC |
Chief Medical Officer |
2005-11-22 |
5,000 |
2005-11-22 |
0 |
Premium* |
|
|
Celldex Therapeutics Inc |
CLDX |
Sr. VP & CMO |
2010-09-16 |
1,011 |
2009-01-06 |
0 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
CHIEF MEDICAL OFFICER |
2022-04-04 |
68,330 |
2020-04-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNCA |
Genocea Biosciences, Inc. |
CHIEF MEDICAL OFFICER |
• – – |
2022-04-04 |
4 |
S |
$1.25 |
$1,364 |
D/D |
(1,091) |
68,330 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
CHIEF MEDICAL OFFICER |
• – – |
2022-03-16 |
4 |
S |
$1.10 |
$2,989 |
D/D |
(2,717) |
69,421 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
CHIEF MEDICAL OFFICER |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
72,138 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
CHIEF MEDICAL OFFICER |
• – – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
31,250 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
CHIEF MEDICAL OFFICER |
• – – |
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
6,623 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
CHIEF MEDICAL OFFICER |
• – – |
2020-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,299 |
12,299 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Sr. VP & CMO |
• – – |
2010-09-16 |
4 |
B |
$3.77 |
$9,435 |
D/D |
2,500 |
1,011 |
2.74 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Sr. VP & CMO |
• – – |
2009-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,868 |
5,868 |
0 |
- |
|
| GNVC |
Genvec Inc |
officerTitle |
• – – |
2005-11-22 |
4 |
B |
$1.82 |
$9,100 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
